%0 Journal Article
%T Long-Term Treatment of Metastatic Colorectal Cancer with Panitumumab
%A Miriam L¨®pez-G¨®mez
%A Mar¨ªa Merino and Enrique Casado
%J Clinical Medicine Insights: Oncology
%D 2012
%I 
%R 10.4137/CMO.S5055
%X Colorectal cancer is one of the leading causes of cancer-related deaths worldwide. More than 30% patients present with metastases at diagnoses and will require systemic chemotherapy. In recent years many anti-EGFR targets have been developed. Among them, panitumumab, a fully human IgG2 monoclonal antibody has shown important benefits in the treatment of this disease.
%U http://www.la-press.com/long-term-treatment-of-metastatic-colorectal-cancer-with-panitumumab-article-a3075